LIU, D., M. WANG, V. MURTHY, D. M. MCNAMARA, T. T. L. NGUYEN, T. J. PHILIPS, H. VYAS, H. GAO, J. SAHNI, R. C. STARLING, L. T. COOPER, M. K. SKIME, A. BATZLER, G. D. JENKINS, S. BARLERA, S. PILEGGI, L. MESTRONI, M. MERLO, G. SINAGRA, F. PINET, Jan KREJČÍ, Anna CHALOUPKA, J. D. MILLER, P. DE GROOTE, D. J. TSCHUMPERLIN, R. M. WEINSHILBOUM and N. L. PEREIRA. Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis. CIRCULATION RESEARCH. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 133, No 10, p. 810-825. ISSN 0009-7330. Available from: https://dx.doi.org/10.1161/CIRCRESAHA.123.323200.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis
Authors LIU, D., M. WANG, V. MURTHY, D. M. MCNAMARA, T. T. L. NGUYEN, T. J. PHILIPS, H. VYAS, H. GAO, J. SAHNI, R. C. STARLING, L. T. COOPER, M. K. SKIME, A. BATZLER, G. D. JENKINS, S. BARLERA, S. PILEGGI, L. MESTRONI, M. MERLO, G. SINAGRA, F. PINET, Jan KREJČÍ (203 Czech Republic, belonging to the institution), Anna CHALOUPKA (203 Czech Republic, belonging to the institution), J. D. MILLER, P. DE GROOTE, D. J. TSCHUMPERLIN, R. M. WEINSHILBOUM and N. L. PEREIRA (guarantor).
Edition CIRCULATION RESEARCH, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2023, 0009-7330.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 20.100 in 2022
RIV identification code RIV/00216224:14110/23:00132227
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1161/CIRCRESAHA.123.323200
UT WoS 001098230800003
Keywords in English cardiomyopathy dilated; fibrosis; genetics; genome-wide association study; heart failure; humansventricular remodeling
Tags 14110115, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/2/2024 08:41.
Abstract
BACKGROUND: Dilated cardiomyopathy (DCM) is a major cause of heart failure and carries a high mortality rate. Myocardial recovery in DCM-related heart failure patients is highly variable, with some patients having little or no response to standard drug therapy. A genome-wide association study may agnostically identify biomarkers and provide novel insight into the biology of myocardial recovery in DCM.METHODS: A genome-wide association study for change in left ventricular ejection fraction was performed in 686 White subjects with recent-onset DCM who received standard pharmacotherapy. Genome-wide association study signals were subsequently functionally validated and studied in relevant cellular models to understand molecular mechanisms that may have contributed to the change in left ventricular ejection fraction.RESULTS: The genome-wide association study identified a highly suggestive locus that mapped to the 5 '-flanking region of the CDCP1 (CUB [complement C1r/C1s, Uegf, and Bmp1] domain containing protein 1) gene (rs6773435; P=7.12x10-7). The variant allele was associated with improved cardiac function and decreased CDCP1 transcription. CDCP1 expression was significantly upregulated in human cardiac fibroblasts (HCFs) in response to the PDGF (platelet-derived growth factor) signaling, and knockdown of CDCP1 significantly repressed HCF proliferation and decreased AKT (protein kinase B) phosphorylation. Transcriptomic profiling after CDCP1 knockdown in HCFs supported the conclusion that CDCP1 regulates HCF proliferation and mitosis. In addition, CDCP1 knockdown in HCFs resulted in significantly decreased expression of soluble ST2 (suppression of tumorigenicity-2), a prognostic biomarker for heart failure and inductor of cardiac fibrosis.CONCLUSIONS: CDCP1 may play an important role in myocardial recovery in recent-onset DCM and mediates its effect primarily by attenuating cardiac fibrosis.
Links
MUNI/A/1410/2022, interní kód MUName: Nové trendy v diagnostice a managementu srdečních onemocnění
Investor: Masaryk University, New trends in diagnostics and management of cardiac diseases
PrintDisplayed: 23/7/2024 22:16